Selected research
Market Outlook & Growth Opportunities
Global Cell and Gene Therapy Bioanalytical Testing Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Cell and Gene Therapy Bioanalytical Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Cell and Gene Therapy Bioanalytical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cell and Gene Therapy Bioanalytical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell and Gene Therapy Bioanalytical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Cell and Gene Therapy Bioanalytical Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Cell and Gene Therapy Bioanalytical Testing Services market include BioAgilytix Labs, KCAS Bioanalytical Services, Laboratory Corporation of America Holdings, Pharmaceutical Product Development, Inc., Prolytix, Pharmaron, Charles River Laboratories, Syneos Health and SGS SA, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Cell and Gene Therapy Bioanalytical Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell and Gene Therapy Bioanalytical Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell and Gene Therapy Bioanalytical Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell and Gene Therapy Bioanalytical Testing Services market.
Cell and Gene Therapy Bioanalytical Testing Services Segment by Company
BioAgilytix Labs
KCAS Bioanalytical Services
Laboratory Corporation of America Holdings
Pharmaceutical Product Development, Inc.
Prolytix
Pharmaron
Charles River Laboratories
Syneos Health
SGS SA
CD BioSciences
Cell and Gene Therapy Bioanalytical Testing Services Segment by Type
Gene Therapy
Gene-modified Cell Therapy
Cell Therapy
Cell and Gene Therapy Bioanalytical Testing Services Segment by Application
Non-clinical Contract Manufacturing Organizations
Pharma and Biopharma Companies
Contract Research Organizations
Others
Cell and Gene Therapy Bioanalytical Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Cell and Gene Therapy Bioanalytical Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Cell and Gene Therapy Bioanalytical Testing Services key companies, revenue, market share, and recent developments.
3. To split the Cell and Gene Therapy Bioanalytical Testing Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Cell and Gene Therapy Bioanalytical Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cell and Gene Therapy Bioanalytical Testing Services significant trends, drivers, influence factors in global and regions.
6. To analyze Cell and Gene Therapy Bioanalytical Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Bioanalytical Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Bioanalytical Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Bioanalytical Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy Bioanalytical Testing Services industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Bioanalytical Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Cell and Gene Therapy Bioanalytical Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Cell and Gene Therapy Bioanalytical Testing Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Cell and Gene Therapy Bioanalytical Testing Services Industry Trends
Table 2. Cell and Gene Therapy Bioanalytical Testing Services Industry Drivers
Table 3. Cell and Gene Therapy Bioanalytical Testing Services Industry Opportunities and Challenges
Table 4. Cell and Gene Therapy Bioanalytical Testing Services Industry Restraints
Table 5. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Company (2021-2026)
Table 7. Global Cell and Gene Therapy Bioanalytical Testing Services Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Cell and Gene Therapy Bioanalytical Testing Services Key Company Manufacturing Base & Headquarters
Table 9. Global Cell and Gene Therapy Bioanalytical Testing Services Company, Product Type & Application
Table 10. Global Cell and Gene Therapy Bioanalytical Testing Services Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Cell and Gene Therapy Bioanalytical Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Gene Therapy
Table 15. Significant Companies of Gene-modified Cell Therapy
Table 16. Significant Companies of Cell Therapy
Table 17. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type (2021-2026)
Table 21. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Non-clinical Contract Manufacturing Organizations
Table 23. Significant Companies of Pharma and Biopharma Companies
Table 24. Significant Companies of Contract Research Organizations
Table 25. Significant Companies of Others
Table 26. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Application (2021-2026) & (US$ Million)
Table 28. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Application (2027-2032) & (US$ Million)
Table 29. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application (2021-2026)
Table 30. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application (2027-2032)
Table 31. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Region (2021-2026) & (US$ Million)
Table 33. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Region (2021-2026)
Table 34. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Region (2027-2032) & (US$ Million)
Table 35. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Region (2027-2032)
Table 36. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Country (2021-2026) & (US$ Million)
Table 38. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Market Share by Country (2021-2026)
Table 39. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Country (2027-2032) & (US$ Million)
Table 40. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Market Share by Country (2027-2032)
Table 41. BioAgilytix Labs Company Information
Table 42. BioAgilytix Labs Business Overview
Table 43. BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 45. BioAgilytix Labs Recent Development
Table 46. KCAS Bioanalytical Services Company Information
Table 47. KCAS Bioanalytical Services Business Overview
Table 48. KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 49. KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 50. KCAS Bioanalytical Services Recent Development
Table 51. Laboratory Corporation of America Holdings Company Information
Table 52. Laboratory Corporation of America Holdings Business Overview
Table 53. Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 54. Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 55. Laboratory Corporation of America Holdings Recent Development
Table 56. Pharmaceutical Product Development, Inc. Company Information
Table 57. Pharmaceutical Product Development, Inc. Business Overview
Table 58. Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 60. Pharmaceutical Product Development, Inc. Recent Development
Table 61. Prolytix Company Information
Table 62. Prolytix Business Overview
Table 63. Prolytix Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 64. Prolytix Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 65. Prolytix Recent Development
Table 66. Pharmaron Company Information
Table 67. Pharmaron Business Overview
Table 68. Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 69. Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 70. Pharmaron Recent Development
Table 71. Charles River Laboratories Company Information
Table 72. Charles River Laboratories Business Overview
Table 73. Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 75. Charles River Laboratories Recent Development
Table 76. Syneos Health Company Information
Table 77. Syneos Health Business Overview
Table 78. Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 79. Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 80. Syneos Health Recent Development
Table 81. SGS SA Company Information
Table 82. SGS SA Business Overview
Table 83. SGS SA Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 84. SGS SA Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 85. SGS SA Recent Development
Table 86. CD BioSciences Company Information
Table 87. CD BioSciences Business Overview
Table 88. CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
Table 90. CD BioSciences Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Authors List of This Report
Table 93. Secondary Sources
Table 94. Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy Bioanalytical Testing Services Product Image
Figure 2. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million)
Figure 4. Global Cell and Gene Therapy Bioanalytical Testing Services Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Gene Therapy Image
Figure 8. Gene-modified Cell Therapy Image
Figure 9. Cell Therapy Image
Figure 10. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type (2021-2032)
Figure 13. Non-clinical Contract Manufacturing Organizations Image
Figure 14. Pharma and Biopharma Companies Image
Figure 15. Contract Research Organizations Image
Figure 16. Others Image
Figure 17. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 18. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share 2021 VS 2025 VS 2032
Figure 19. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application (2021-2032)
Figure 20. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 21. Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 22. North America Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032) & (US$ Million)
Figure 23. North America Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Europe Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032) & (US$ Million)
Figure 25. Europe Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Asia-Pacific Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032) & (US$ Million)
Figure 27. Asia-Pacific Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country (%), 2025 VS 2032
Figure 28. South America Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032) & (US$ Million)
Figure 29. South America Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country (%), 2025 VS 2032
Figure 30. Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032) & (US$ Million)
Figure 31. Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country (%), 2025 VS 2032
Figure 32. USA Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. USA Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. USA Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Canada Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Canada Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Canada Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Mexico Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Mexico Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Mexico Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. Germany Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. Germany Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. Germany Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. France Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. France Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. France Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. U.K. Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. U.K. Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. U.K. Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Italy Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Italy Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Italy Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Spain Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Spain Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Spain Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Russia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Russia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Russia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Netherlands Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Netherlands Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Netherlands Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Nordic Countries Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Nordic Countries Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Nordic Countries Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. China Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. China Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. China Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. Japan Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. Japan Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. Japan Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. South Korea Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. South Korea Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. South Korea Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. India Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. India Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. India Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Australia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Australia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Australia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Southeast Asia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Southeast Asia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Southeast Asia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Brazil Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Brazil Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Brazil Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Argentina Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Argentina Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Argentina Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Chile Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Chile Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Chile Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Colombia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Colombia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Colombia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Peru Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Peru Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Peru Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Saudi Arabia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Israel Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Israel Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Israel Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. UAE Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. UAE Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. UAE Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Turkey Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Turkey Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Turkey Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Iran Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Iran Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Iran Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Egypt Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Egypt Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Egypt Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Years Considered
Figure 117. Research Process
Figure 118. Key Executives Interviewed
Scope & coverage.
Types
- Gene Therapy
- Gene-modified Cell Therapy
- Cell Therapy
Applications
- Non-clinical Contract Manufacturing Organizations
- Pharma and Biopharma Companies
- Contract Research Organizations
- Others
Companies covered
- BioAgilytix Labs
- KCAS Bioanalytical Services
- Laboratory Corporation of America Holdings
- Pharmaceutical Product Development, Inc.
- Prolytix
- Pharmaron
- Charles River Laboratories
- Syneos Health
- SGS SA
- CD BioSciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cell and Gene Therapy Bioanalytical Testing Services Market Dynamics
- 2.1 Cell and Gene Therapy Bioanalytical Testing Services Industry Trends
- 2.2 Cell and Gene Therapy Bioanalytical Testing Services Industry Drivers
- 2.3 Cell and Gene Therapy Bioanalytical Testing Services Industry Opportunities and Challenges
- 2.4 Cell and Gene Therapy Bioanalytical Testing Services Industry Restraints
3 Cell and Gene Therapy Bioanalytical Testing Services Market by Company
- 3.1 Global Cell and Gene Therapy Bioanalytical Testing Services Company Revenue Ranking in 2025
- 3.2 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Company (2021-2026)
- 3.3 Global Cell and Gene Therapy Bioanalytical Testing Services Company Ranking (2024-2026)
- 3.4 Global Cell and Gene Therapy Bioanalytical Testing Services Company Manufacturing Base and Headquarters
- 3.5 Global Cell and Gene Therapy Bioanalytical Testing Services Company Product Type and Application
- 3.6 Global Cell and Gene Therapy Bioanalytical Testing Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Cell and Gene Therapy Bioanalytical Testing Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Cell and Gene Therapy Bioanalytical Testing Services Market by Type
- 4.1 Cell and Gene Therapy Bioanalytical Testing Services Type Introduction
- 4.1.1 Gene Therapy
- 4.1.2 Gene-modified Cell Therapy
- 4.1.3 Cell Therapy
- 4.2 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Type
- 4.2.1 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Type (2021-2032)
- 4.2.3 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type (2021-2032)
5 Cell and Gene Therapy Bioanalytical Testing Services Market by Application
- 5.1 Cell and Gene Therapy Bioanalytical Testing Services Application Introduction
- 5.1.1 Non-clinical Contract Manufacturing Organizations
- 5.1.2 Pharma and Biopharma Companies
- 5.1.3 Contract Research Organizations
- 5.1.4 Others
- 5.2 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Application
- 5.2.1 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Application (2021-2032)
- 5.2.3 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application (2021-2032)
6 Cell and Gene Therapy Bioanalytical Testing Services Regional Value Analysis
- 6.1 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Region (2021-2032)
- 6.2.1 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Region: 2021-2026
- 6.2.2 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032)
- 6.3.2 North America Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032)
- 6.4.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032)
- 6.6.2 South America Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Country, 2025 VS 2032
7 Cell and Gene Therapy Bioanalytical Testing Services Country-level Value Analysis
- 7.1 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Country (2021-2032)
- 7.2.1 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Country (2021-2026)
- 7.2.2 Global Cell and Gene Therapy Bioanalytical Testing Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Cell and Gene Therapy Bioanalytical Testing Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Cell and Gene Therapy Bioanalytical Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 BioAgilytix Labs
- 8.1.1 BioAgilytix Labs Company Information
- 8.1.2 BioAgilytix Labs Business Overview
- 8.1.3 BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.1.4 BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.1.5 BioAgilytix Labs Recent Developments
- 8.2 KCAS Bioanalytical Services
- 8.2.1 KCAS Bioanalytical Services Company Information
- 8.2.2 KCAS Bioanalytical Services Business Overview
- 8.2.3 KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.2.4 KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.2.5 KCAS Bioanalytical Services Recent Developments
- 8.3 Laboratory Corporation of America Holdings
- 8.3.1 Laboratory Corporation of America Holdings Company Information
- 8.3.2 Laboratory Corporation of America Holdings Business Overview
- 8.3.3 Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.3.5 Laboratory Corporation of America Holdings Recent Developments
- 8.4 Pharmaceutical Product Development, Inc.
- 8.4.1 Pharmaceutical Product Development, Inc. Company Information
- 8.4.2 Pharmaceutical Product Development, Inc. Business Overview
- 8.4.3 Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.4.5 Pharmaceutical Product Development, Inc. Recent Developments
- 8.5 Prolytix
- 8.5.1 Prolytix Company Information
- 8.5.2 Prolytix Business Overview
- 8.5.3 Prolytix Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Prolytix Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.5.5 Prolytix Recent Developments
- 8.6 Pharmaron
- 8.6.1 Pharmaron Company Information
- 8.6.2 Pharmaron Business Overview
- 8.6.3 Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.6.5 Pharmaron Recent Developments
- 8.7 Charles River Laboratories
- 8.7.1 Charles River Laboratories Company Information
- 8.7.2 Charles River Laboratories Business Overview
- 8.7.3 Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.7.5 Charles River Laboratories Recent Developments
- 8.8 Syneos Health
- 8.8.1 Syneos Health Company Information
- 8.8.2 Syneos Health Business Overview
- 8.8.3 Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.8.5 Syneos Health Recent Developments
- 8.9 SGS SA
- 8.9.1 SGS SA Company Information
- 8.9.2 SGS SA Business Overview
- 8.9.3 SGS SA Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.9.4 SGS SA Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.9.5 SGS SA Recent Developments
- 8.10 CD BioSciences
- 8.10.1 CD BioSciences Company Information
- 8.10.2 CD BioSciences Business Overview
- 8.10.3 CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
- 8.10.4 CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
- 8.10.5 CD BioSciences Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst